Filter By

STRIVE-ON: Safety and Tolerability of GTX-104 (Intravenous Nimodipine) Versus Oral Nimodipine in Aneurysmal subarachnoid hemorrhage: a Prospective, Randomized Trial. International Stroke Conference (2024)

View Publication

GTX-104, Novel IV Formulation of Nimodipine to Treat Subarachnoid Hemorrhage a Pharmacokinetic Comparison with Oral Nimodipine. Neurocritical Care Society Annual Meeting (2023)

View Publication

Guideline for the Management of Patients With Aneurysmal subarachnoid hemorrhage: A Guideline From the American Heart Association/ American Stroke Association. Hoh BL, et al. Stroke (2023). DOI: 10.1161/STR.0000000000000436

View Publication

Comparison of nimodipine formulations and administration techniques via enteral feeding tubes in patients with subarachnoid hemorrhage: A multicenter retrospective cohort study. Mahmoud SH, et al. Pharmacotherapy (2023); 43:279-290. DOI: 10.1002/phar.2791.

View Publication

The impact of nimodipine administration through feeding tube on outcomes in patients with aneurysmal subarachnoid hemorrhage. Isse FA, et al. J Pharm Sci. (2020);23 (1):100–108. DOI: 10.18433/jpps30960.

View Publication

Nimodipine Pharmacokinetic Variability in Various Patient Populations. Mahmoud SH, et al. Drugs in R&D (2020);20(4):307–318. DOI: 10.1007/s40268-020-00322-3

View Publication